November
Drug Discovery Biology
Strategy Meeting East Coast USA 2023
Understanding Complex Structure, Properties and Dynamics of Biological Phenomena in Drug Discovery: Emerging Tools and Next Generation Drug Target Characterization, Validation and Safety Profiling
What makes our strategy meetings unique?

Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our Past Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Drug Discovery Biology strategy meeting.

Henry Lu
VP & Head of Discovery Biology WuXi AppTec
Letian Kuai, Ph.D
Executive Director, DEL Technology and Strategy Chief Scientific Officer, Crelux WuXi AppTec
Andreas Schoops
Head of Medicinal Chemistry WuXi AppTec
Dominic Hussey
Territorial Head-EMEA Sales Bit.Bio
Frank Kruse
Vice President of Marketing and Business Development Sekisui Xenotech
Terri Almos
Executive Director, Emerging Science & Innovation Inflammation & Immunology Pfizer
Karim Azer
VP, Head of Platform & Discovery Axcella
Carla Bauer
Associate Director, Strategic Transactions, Business Development & Licensing Novartis
Govinda Bhisetti
Vice President and Head of Computational Chemistry Cellarity
Matthew Calabrese
Senior Director and Head of Structural and Molecular Sciences Pfizer
Prasoon Chaturvedi
Vice President, Head of DMPK C4 Therapeutics, Inc.
Brent Cezairliyan
Vice President, Biology Octagon Therapeutics
Rob Foti
Senior Director, Preclinical Development (ADME & Discovery Toxicology) MERCK
Vibha Jawa
Executive Director, Nonclinical Disposition and Bioanalysis Bristol Myers Squibb
Matthew Lech
Principal Research Scientist Pfizer
Jing Li
Executive Director Biology PTC Therapeutics, Inc.
Diane Joseph McCarthy
Executive Director, Bioengineering Technology & Entrepreneurship Center Boston University
Li Peng
Chief Scientific Officer Palleon Pharmaceuticals
Nisha Perez
Senior Director, Head of DMPK ROME Therapeutics
John Reilly
Chief Scientific Officer Nereid Therapeutics
Cara Williams
Vice President Head of Preclinical Biology: Inflammation & Immunology Research Unit PfizerWho Should Attend the Event?
Chief Scientific Officer
Vice President, Head Research Pharmacokinetics
Global Head, Modeling and Simulation
Vice President of Biology
Head of Discovery Chemistry, Screening Biology & Operations
Head of Discovery Biology
Head of Structural Biology & Biophysics
Head of Target Science, Target & Translational Science
Head of Protein & Structural Sciences
Head of Pharmacology
Discovery DMPK & ADME
Drug Metabolism & Pharmacokinetics
See Which Topics Are Discussed at the Strategy Meeting
Roundtable Tracks
1Roundtable Tracks
2Why should you attend this meeting?

Understanding recent advances and alternatives for drug discovery stages discovery, development and preclinical stages that could lead to cost cutting, efficiency and early detection





Leveraging multi-omics analysis data, its advantages and limitations to further the possibilities for drug discovery applications





Exploring the discrepancy in drug metabolism between different genders and ethnic diversification that could lead to understanding the pharmacokinetics distinction between genders and ethnicity





Collaborative approaches and networking opportunities with different top-tier industry solution providers






Press play to hear what your colleagues had to say…
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team?rnrnJust get in touch and a member of the team will be happy to help.
Want to find out more?
Find out more details about our Strategy Meetings and other news and events.